Question 1

Has Evelyn Acosta received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $13,553 in general payments to Evelyn Acosta across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Evelyn Acosta did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Evelyn Acosta come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Insulet Corporation	52	$6,838
Sanofi-aventis U.S. LLC	9	$4,255
AbbVie	20	$387
AstraZeneca	6	$289
Tolmar, Inc.	12	$252
Novo Nordisk	9	$225
Ascendis Pharma Endocrinology Inc	3	$205
Kyowa Kirin, Inc.	3	$162
GSK	3	$158
BETA Bionics, Inc.	1	$134
Dexcom, Inc.	1	$121
Azurity Pharmaceuticals, Inc.	6	$114
Acadia Pharmaceuticals Inc	2	$101
Tandem Diabetes Care, Inc.	1	$52
Takeda Pharmaceuticals U.S.A., Inc.	2	$42
Rhythm Pharmaceuticals, Inc.	2	$40
Tolmar Pharmaceuticals, Inc.	2	$35
Arbor Pharmaceuticals, Inc.	2	$32
Pfizer	2	$31
Lilly USA, LLC	1	$25
Neurocrine Biosciences, Inc.	1	$21
Xeris Pharmaceuticals, Inc.	1	$19
Neurelis, Inc.	1	$15

Evelyn Acosta

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other pediatrics in El Paso